Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital March 25, 2021
Clearlake Capital and Insight Partners-backed Appriss Health Acquires PatientPing to Deliver Comprehensive Care Coordination Solutions March 23, 2021
Citrine Medicine Announces Receipt of Clinical Trial Waiver from the National Medical Products Administration (NMPA) in China for Narcolepsy Therapy Wakix® (pitolisant) and Partnership With Chinese Alliance for Rare Diseases (CARD) March 22, 2021
WellAir Announces Appointment of Brad Niemann as Executive Vice President of Healthcare March 18, 2021
OZiva raises $12M Series B investment by Eight Road Ventures, F-Prime Capital, and Matrix Partners Read more at: https://yourstory.com/2021/03/funding-alert-oziva-raises-12-million-series-b-investment March 17, 2021
FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies March 17, 2021
Adagene Announces First Patients Dosed in Global Phase 1 Clinical Trial of ADG126, Lead SAFEbody™ Program March 16, 2021